Antimicrobials, a broad category of medications, play a pivotal role in combating various microorganisms, including bacteria, viruses, fungi, and parasites. Antibiotics, a subset of antimicrobials, specifically target bacteria, disrupting their growth or causing their demise. Common antibiotics like penicillins, cephalosporins, and tetracyclines have revolutionized medicine, transforming the landscape of infectious disease treatment. Antivirals, another subgroup, focus on viral infections, inhibiting viral replication or entry into host cells. Medications such as oseltamivir (Tamiflu) for influenza exemplify the antiviral class. Antifungals combat fungal infections, and antiparasitics target parasitic organisms, collectively contributing to the comprehensive field of antimicrobial therapeutics. However, the emergence of drug-resistant strains poses a global health threat, necessitating the development of novel antimicrobials, enhanced diagnostics, and robust stewardship programs to optimize their use and mitigate resistance.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Gendered socioeconomic impacts of emerging infectious diseases: Insights from a mixed-methods study in Guinea
Stephanie Maltais, University of Montreal, Canada
Title : The role of social sciences in operationalizing the One Health approach: A case study of the DOPERAUS project in Guinea and the Democratic Republic of Congo
Stephanie Maltais, University of Montreal, Canada